The pre-habilitation program for women undergoing surgical treatment for breast cancer addresses a significant unmet need in oncology care, particularly in Brazil, where breast cancer is the most prevalent cancer among women. With an estimated 625,000 new cancer cases annually, this trial could position the Instituto Nacional de Cancer as a leader in innovative cancer care strategies. The findings may support the integration of pre-habilitation programs into standard oncology practice, potentially influencing reimbursement policies and expanding market opportunities for related health and wellness products. The competitive landscape includes other supportive care interventions, but this trial's focus on physical exercise and nutritional guidance may differentiate it in the market. Stakeholders should monitor the trial's outcomes closely for implications on treatment protocols and potential partnerships with health organizations.